IMUN Stock Price, News & Analysis

IMUN OTC

Company Description

IMUN (OTC: IMUN) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

IMUN stock has declined 90.7% over the past year.

This page provides a comprehensive overview of IMUN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-90.67%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

IMUN (IMUN) stock. Over the past 12 months, the stock has lost 90.7%.

Latest News

View All

September 14, 2023

0.00%

Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky

August 29, 2023

0.00%

Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV

August 15, 2023

0.00%

Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH

fda approval

May 30, 2023

0.00%

Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare

April 20, 2023

0.00%

Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies

March 1, 2023

0.00%

Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction

IMUN has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include fda approval, management. View all IMUN news →

SEC Filings

View All

No SEC filings available for IMUN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMUN Company Profile & Sector Positioning

IMUN (IMUN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.